AI Verdict
MA has stronger fundamentals based on our AI analysis.
CME vs MA Fundamental Comparison
| Metric | CME | MA |
|---|---|---|
| Revenue | $6.5B | $32.8B |
| Net Income | $4.1B | $15.0B |
| Net Margin | 62.5% | 45.6% |
| ROE | 14.2% | 193.5% |
| ROA | 2.1% | 27.6% |
| Current Ratio | 1.03x | 1.03x |
| Debt/Equity | 0.00x | 2.36x |
| EPS | $11.16 | $16.52 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
CME vs MA: Frequently Asked Questions
Is CME or MA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MA has stronger fundamentals. CME is rated BUY (86% confidence) while MA is rated STRONG BUY (92% confidence). This is not investment advice.
How does CME compare to MA fundamentally?
CME GROUP INC. has ROE of 14.2% vs Mastercard Inc's 193.5%. Net margins are 62.5% vs 45.6% respectively.
Which stock pays higher dividends, CME or MA?
CME has a dividend yield of N/A or no dividend while MA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in CME or MA for long term?
For long-term investing, consider that CME has BUY rating with 86% confidence, while MA has STRONG BUY rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about CME vs MA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CME vs MA, the AI consensus favors MA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.